Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies. (Q44637210)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

0 references

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Robert Wieder

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Steven C Novick

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Bruce W Hollis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Margarette Bryan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Suzanne M Chanel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Kate Owusu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Danielle Camastra

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Tracie Saunders

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Lillian Pliner

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Peter Bonate

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Tom Williams

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Steven Soignet

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

445-452

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14586212%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1026203418976

20 December 2019

exact match

0 references

cites work

1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.

1 reference

12 December 2020

Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion

1 reference

12 December 2020

Role of apoptosis in the growth inhibitory effects of vitamin D in MCF-7 cells.

1 reference

12 December 2020

1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms

1 reference

12 December 2020

Inhibitory effect of 1 alpha,25-dihydroxyvitamin D3 on the growth of the renal carcinoma cell line

1 reference

12 December 2020

Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells

1 reference

12 December 2020

The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer

1 reference

12 December 2020

Vitamin D metabolites change the phenotype of monoblastic U937 cells

1 reference

12 December 2020

Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma

1 reference

12 December 2020

Two nuclear signalling pathways for vitamin D

1 reference

12 December 2020

Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant

1 reference

12 December 2020

Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells

1 reference

12 December 2020

Phorbol esters, but not the hormonal form of vitamin D, induce changes in protein kinase C during differentiation of human histiocytic lymphoma cell line (U-937)

1 reference

12 December 2020

The vitamin D story: a collaborative effort of basic science and clinical medicine.

1 reference

12 December 2020

1,25-dihydroxyvitamin D3 increases the sensitivity of human renal carcinoma cells to tumor necrosis factor alpha but not to interferon alpha or lymphokine-activated killer cells

1 reference

12 December 2020

Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines

1 reference

12 December 2020

Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.

1 reference

12 December 2020

Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol)

1 reference

12 December 2020

EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells

1 reference

12 December 2020

1,25-Dihydroxyvitamin D3-induced growth restriction of cultured epithelial cells derived from a murine hepatic tumor

1 reference

12 December 2020

Induction of androgen receptor by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells

1 reference

12 December 2020

1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration

1 reference

12 December 2020

Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089

1 reference

12 December 2020

Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation

1 reference

12 December 2020

A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy

1 reference

12 December 2020

Evolving concepts in the systemic drug therapy of breast cancer

1 reference

12 December 2020

1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice

1 reference

12 December 2020

The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma

1 reference

12 December 2020

The role of the vitamin D endocrine system in health and disease

1 reference

12 December 2020

Cyclin-dependent kinase 6 is the principal target of p27/Kip1 regulation of the G1-phase traverse in 1,25-dihydroxyvitamin D3-treated HL60 cells

1 reference

12 December 2020

Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization

1 reference

12 December 2020

Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.

1 reference

12 December 2020

Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer

1 reference

12 December 2020

Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2

1 reference

12 December 2020

1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo

1 reference

12 December 2020

Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system

1 reference

12 December 2020

1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects

1 reference

12 December 2020

Effect of 1 alpha-hydroxyvitamin D3 on metastasis of rat ascites hepatoma K-231.

1 reference

12 December 2020

Differential effects of vitamin D on normal human prostate epithelial and stromal cells in primary culture

1 reference

12 December 2020

Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system

1 reference

12 December 2020

The role of vitamin D3 receptor mRNA in the proliferation of hepatocellular carcinoma

1 reference

12 December 2020

1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells

1 reference

12 December 2020